Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B (900904) — Cash Flow-to-Debt Ratio
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B (900904) has a Cash Flow-to-Debt Ratio of 0.13x as of June 2023, meaning its operating cash flow of $118.87 Million could theoretically repay 0% of its total liabilities ($900.37 Million) in one year. Explore Shanghai Shenqi Pharmaceutical Investmen strategic investment ratio to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B Cash Flow-to-Debt Ratio (2015–2024)
Historical debt coverage capacity for Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B across 10 annual periods. Also explore Shanghai Shenqi Pharmaceutical Investmen asset portfolio for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B (2015–2024)
Year-by-year debt coverage analysis for Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B. For market capitalisation and broader financial context, see Shanghai Shenqi Pharmaceutical Investmen market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.30x | $207.79 Million | $689.01 Million | ▲ +24.3% |
| 2023 | 0.24x | $215.59 Million | $888.77 Million | ▼ -22.9% |
| 2022 | 0.31x | $319.23 Million | $1.01 Billion | ▲ +29.2% |
| 2021 | 0.24x | $184.26 Million | $756.45 Million | ▲ +89.3% |
| 2020 | 0.13x | $99.10 Million | $770.28 Million | ▼ -10.3% |
| 2019 | 0.14x | $128.28 Million | $894.60 Million | ▼ -49.0% |
| 2018 | 0.28x | $148.53 Million | $527.74 Million | ▲ +137.5% |
| 2017 | 0.12x | $66.99 Million | $565.34 Million | ▲ +11690.0% |
| 2016 | 0.00x | $570.41K | $567.56 Million | ▼ -98.7% |
| 2015 | 0.08x | $30.12 Million | $384.98 Million | — |